![최근 리보세라닙 케이스 리포트 논문이 수정됐습니다!](https://poortechguy.com/image/whgi2fYzWvY.webp)
최근 리보세라닙 케이스 리포트 논문이 수정됐습니다!
#rivoceranib_paper #A 2023 01 01 αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib 2023 Correction: αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib